Comparison of Endotracheal Intubation Over the Aintree With Fiberoptic Bronchoskop Via the I-gel and LMA Protector
1 other identifier
interventional
80
1 country
1
Brief Summary
Investigators aimed to compare the ease of use of the LMA protector and I-gel LMA for tracheal intubation with the Aintree catheter in our study. Laryngeal mask airway (LMA) protector is the second generation perilaryngeal seal type supraglottic airway tool. The I-gel LMA is the second generation uncuffed supraglottic airway device. The Aintree Intubation Catheter has been designed for assisted fiberoptic intubation and for uncomplicated, atraumatic endotracheal tube exchange.Both LMA types have a structure that permits endotracheal intubation. In cases of difficult intubation, these two LMA types can be used. In the literature, there is no study comparing these two LMA types using Aintree catheter.Difficult Airway Society (DAS) published a guide for tracheal intubation in 2011 using Aintree. According to this guide, LMA type LMA Supreme is the most unfavorable for this process. However, there is no research or recommendation on the type of LMA most suitable for use in the literature. In accordance with the data of this study, it will be tried to show which LMA type may be suitable for intubation with Aintree catheter in patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 5, 2018
CompletedFirst Submitted
Initial submission to the registry
April 10, 2018
CompletedFirst Posted
Study publicly available on registry
April 18, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 5, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 5, 2019
CompletedApril 19, 2018
April 1, 2018
1 year
April 10, 2018
April 17, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time to Successful Tracheal Intubation
This measure of time begins with the handling of the supraglottic device to confirming the appropriate placement of the device by noting the presences of end tidal carbon dioxide.
Up to 10 minutes
Secondary Outcomes (3)
Time to Placement of the Supra Glottic Device
Up to 10 minutes
Time to Placement of the Aintree Airway Intubation Catheter
Up to 10 minutes
Laryngeal appearance staging
Up to 10 minutes
Other Outcomes (13)
Mouth openness
Up to 10 minutes
thiromental distance
Up to 10 minutes
pre-induction systolic and diastolic pulse
Up to 10 minutes
- +10 more other outcomes
Study Arms (2)
LMA protector group
ACTIVE COMPARATORThe LMA Protector is a single use supraglottic airway device. This airway device provides access and functional separation of the respiratory and digestive tracts
I-gel LMA group
ACTIVE COMPARATORThe I-gel is an alternative supraglottic device which provides the seal over the airway versus an inflatable cuff.
Interventions
In this arm the LMA protector will be inserted. The time from took the LMA to placement of the LMA will be recorded. In patients with adequate ventilation, an Aintree catheter placed on a fiberoptic bronchoscope in LMA will be delivered. Cord vocals will be seen on the monitor and the aintree catheter will be sent into the trachea. After the insertion of the trachea, the fiberoptic bronchoscope and LMA are removed and the patient's intubation tube is advanced through the Aintree catheter to the patient's trachea. Once you have made sure that the tube is in the trachea, it will be removed. The time from insertion of the LMA to placement of the endotracheal tube will be recorded.
In this arm the I-gel LMA will be inserted. The time from took the LMA to placement of the LMA will be recorded. In patients with adequate ventilation, an Aintree catheter placed on a fiberoptic bronchoscope in LMA will be delivered. Cord vocals will be seen on the monitor and the aintree catheter will be sent into the trachea. After the insertion of the trachea, the fiberoptic bronchoscope and LMA are removed and the patient's intubation tube is advanced through the Aintree catheter to the patient's trachea. Once you have made sure that the tube is in the trachea, it will be removed. The time from insertion of the LMA to placement of the endotracheal tube will be recorded.
Eligibility Criteria
You may qualify if:
- Be intubated in surgical operation requiring intubation
- over 18 years old
You may not qualify if:
- Difficult intubation story
- Difficult intubation risk
- Presence of gastric reflux
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aslı Duygu Aydaş
Kocaeli, Derince, 41900, Turkey (Türkiye)
Study Officials
- STUDY CHAIR
Kemal T Saraçoğlu, assoc. prof.
Sağlık Bilimleri Üniversitesi Kocaeli Derince Eğitim ve Araştırma Hastanesi
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- specialist doctor
Study Record Dates
First Submitted
April 10, 2018
First Posted
April 18, 2018
Study Start
April 5, 2018
Primary Completion
April 5, 2019
Study Completion
July 5, 2019
Last Updated
April 19, 2018
Record last verified: 2018-04